Interim reports

SynAct Pharma: Interim report January-March 2021

“The first three months have indeed given a strong and convincing start of the new year to SynAct Pharma, when we continued to make significant progress on our projects and put the company in a unique p... Read more

Year-end Report 2020

2020-10-01 – 2020-12-31 (fourth quarter) Consolidated net sales amounted to TSEK 0 (0). The Group's profit before tax amounted to TSEK -9 786 (-11 203). The Group's earnings per share amounted to SEK -... Read more

Year-end report for the financial year 2018

SynAct Pharma AB hereby publishes an year-end report for 01/01/2018 – 31/12/2018 Read more

Interim report Q3 2018

Interim report 01/01/2018 - 30/09/2018 Read more

Interim report Q3 2017

01-07-2017 – 30-09-2017 (Third Quarter 2017) Read more

Interim report 3, 2016

The operating subsidiary SynAct Pharma ApS started operations in 2012. SynAct Pharma AB was founded on 12th April 2016. Thus, the group relationship arose 12/04/2016. For this reason, no comparative periods... Read more

Half-yearly Report 2016

The operating subsidiary SynAct Pharma ApS started operations in 2012. SynAct Pharma AB was founded on 12th April 2016. Thus, the group relationship arose 12/04/2016. For this reason, no comparative periods... Read more